Published in J Virol on June 01, 2001
Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice. Am J Respir Crit Care Med (2007) 2.05
Characterization of a spontaneous 9.5-kilobase-deletion mutant of murine gammaherpesvirus 68 reveals tissue-specific genetic requirements for latency. J Virol (2002) 1.25
Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog (2009) 1.23
Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis. J Virol (2003) 1.14
Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo. MBio (2014) 1.04
Herpesvirus microRNAs: phenotypes and functions. Curr Opin Virol (2011) 1.01
Pathogenesis of a model gammaherpesvirus in a natural host. J Virol (2010) 0.99
Gammaherpesvirus small noncoding RNAs are bifunctional elements that regulate infection and contribute to virulence in vivo. MBio (2015) 0.92
Selective uptake of small RNA molecules in the virion of murine gammaherpesvirus 68. J Virol (2008) 0.88
Characterization of a novel wood mouse virus related to murid herpesvirus 4. J Gen Virol (2009) 0.87
Expression in a recombinant murid herpesvirus 4 reveals the in vivo transforming potential of the K1 open reading frame of Kaposi's sarcoma-associated herpesvirus. J Virol (2004) 0.79
T-cell responses to the M3 immune evasion protein of murid gammaherpesvirus 68 are partially protective and induced with lytic antigen kinetics. J Virol (2004) 0.78
Role of tachykinins in the host response to murine gammaherpesvirus infection. J Virol (2001) 0.78
Epstein-Barr virus IL-10 gene expression by a recombinant murine gammaherpesvirus in vivo enhances acute pathogenicity but does not affect latency or reactivation. Herpesviridae (2014) 0.77
A novel Cre recombinase imaging system for tracking lymphotropic virus infection in vivo. PLoS One (2009) 0.77
The m4 gene of murine gammaherpesvirus modulates productive and latent infection in vivo. J Virol (2004) 0.77
Complete genome sequence of Ostreid herpesvirus-1 associated with mortalities of Scapharca broughtonii broodstocks. Virol J (2015) 0.75
Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med (1998) 12.80
Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol (1997) 7.71
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med (1996) 6.08
Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol (1992) 5.42
Primary structure of the herpesvirus saimiri genome. J Virol (1992) 5.26
Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol (1992) 5.02
Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol (1999) 4.12
Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol (2000) 4.09
Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J Virol (1996) 4.02
Nucleotide sequences of the joint between the L and S segments of herpes simplex virus types 1 and 2. J Gen Virol (1981) 3.70
Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol (2000) 3.51
Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med (1998) 3.45
Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J Gen Virol (1990) 3.41
Cloning and molecular characterization of the murine herpesvirus 68 genome. J Gen Virol (1990) 3.33
Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol (1980) 3.09
Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol (1993) 2.93
A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology (1993) 2.78
Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J Virol (1999) 2.56
Natural history of murine gamma-herpesvirus infection. Philos Trans R Soc Lond B Biol Sci (2001) 2.50
Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency. J Gen Virol (1997) 2.44
Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med (1998) 2.38
Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. J Gen Virol (1996) 2.37
Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J Virol (2000) 2.33
Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation. J Virol (1989) 2.29
Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J Virol (1984) 2.25
Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J Gen Virol (1996) 2.25
Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes. Proc Natl Acad Sci U S A (1999) 2.19
Deletion of DNA sequence in a nononcogenic variant of Herpesvirus saimiri. J Virol (1984) 2.14
A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med (2000) 2.09
Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J Exp Med (1997) 1.88
Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol (2000) 1.86
Analysis of murine gammaherpesvirus-68 transcription during lytic and latent infection. J Gen Virol (1999) 1.84
Four tRNA-like sequences and a serpin homologue encoded by murine gammaherpesvirus 68 are dispensable for lytic replication in vitro and latency in vivo. J Gen Virol (1998) 1.68
Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells. J Exp Med (2000) 1.61
Herpesvirus saimiri strains from three DNA subgroups have different oncogenic potentials in New Zealand white rabbits. J Virol (1989) 1.50
Kinetic and phenotypic changes in murine lymphocytes infected with murine gammaherpesvirus-68 in vitro. J Gen Virol (1999) 0.99
Chronic infection of Balb/c mice with murine herpesvirus 72 is associated with neoplasm development. Acta Virol (1997) 0.81
Immunophenotypic study of atypical lymphocytes. Generated in peripheral blood and spleen of nude mice After MHV-72 infection. Viral Immunol (2000) 0.77
Replication and persistence of murine herpesvirus 72 in lymphatic system and peripheral blood mononuclear cells of Balb/C mice. Acta Virol (1994) 0.77
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 19.25
The complete DNA sequence of varicella-zoster virus. J Gen Virol (1986) 16.00
Decision rules for the use of radiography in acute ankle injuries. Refinement and prospective validation. JAMA (1993) 5.92
Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol (1992) 5.42
Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol (1992) 5.02
Recombinants between herpes simplex virus types 1 and 2: analyses of genome structures and expression of immediate early polypeptides. J Virol (1978) 4.87
The DNA sequence of equine herpesvirus-1. Virology (1992) 4.36
Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet (1999) 4.23
Nucleotide sequences of the joint between the L and S segments of herpes simplex virus types 1 and 2. J Gen Virol (1981) 3.70
Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J Gen Virol (1987) 3.16
Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol (1993) 2.93
A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology (1993) 2.78
Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice. Antimicrob Agents Chemother (1979) 2.75
Natural history of murine gamma-herpesvirus infection. Philos Trans R Soc Lond B Biol Sci (2001) 2.50
Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Am J Pathol (1994) 2.49
Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J Virol (1984) 2.48
Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. J Gen Virol (1996) 2.37
Fragments from both termini of the herpes simplex virus type 1 genome contain signals required for the encapsidation of viral DNA. Nucleic Acids Res (1983) 2.37
Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. J Virol (2000) 2.35
The DNA sequence of equine herpesvirus 2. J Mol Biol (1995) 2.34
DNA sequence of the herpes simplex virus type 1 gene whose product is responsible for transcriptional activation of immediate early promoters. Nucleic Acids Res (1985) 2.33
Location and orientation of homologous sequences in the genomes of five herpesviruses. J Gen Virol (1983) 2.29
Isolation and characterization of herpes simplex virus type 1 mutants defective in the UL6 gene. Virology (1996) 2.26
Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J Gen Virol (1996) 2.25
The herpes simplex virus type 1 U(L)17 gene encodes virion tegument proteins that are required for cleavage and packaging of viral DNA. J Virol (1998) 2.20
Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes. Proc Natl Acad Sci U S A (1999) 2.19
Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice. J Virol (1996) 2.19
Alphaherpesviruses possess a gene homologous to the protein kinase gene family of eukaryotes and retroviruses. Nucleic Acids Res (1986) 2.18
Genetic relations between varicella-zoster virus and Epstein-Barr virus. J Gen Virol (1987) 2.17
Identification of genes encoding two capsid proteins (VP24 and VP26) of herpes simplex virus type 1. J Gen Virol (1992) 2.14
Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radic Biol Med (1990) 2.13
Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax (1995) 2.04
DNA sequence of the herpes simplex virus type 1 gene encoding glycoprotein gH, and identification of homologues in the genomes of varicella-zoster virus and Epstein-Barr virus. Nucleic Acids Res (1986) 1.99
Structure of the genome termini of varicella-zoster virus. J Gen Virol (1984) 1.97
Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage. J Exp Med (1989) 1.97
Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity. J Gen Virol (1980) 1.96
Identification of a varicella-zoster virus origin of DNA replication and its activation by herpes simplex virus type 1 gene products. J Gen Virol (1986) 1.96
The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase. J Gen Virol (1992) 1.84
Thymidine kinase deletion mutants of herpes simplex virus type 1. J Gen Virol (1982) 1.84
The nuclear receptor co-repressor nrip1 (RIP140) is essential for female fertility. Nat Med (2000) 1.79
Ribonucleotide reductase induced by herpes simplex virus has a virus-specified constituent. J Gen Virol (1983) 1.71
Pathogenesis of herpes simplex virus in congenitally athymic mice: the relative roles of cell-mediated and humoral immunity. J Gen Virol (1982) 1.70
Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response. J Immunol (1981) 1.66
Identification and sequence of the gene encoding gpIII, a major glycoprotein of varicella-zoster virus. Virology (1987) 1.66
Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein. J Virol (1996) 1.64
The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J Gen Virol (1987) 1.64
Identification of a herpes simplex virus type 1 polypeptide which is a component of the virus-induced ribonucleotide reductase. J Gen Virol (1984) 1.63
Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells. J Exp Med (2000) 1.61
Evolutionary comparisons of the S segments in the genomes of herpes simplex virus type 1 and varicella-zoster virus. J Gen Virol (1986) 1.59
New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. J Virol (1986) 1.59
Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus. Virology (1986) 1.55
Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells. J Virol (1997) 1.54
The DNA sequence of equine herpesvirus-4. J Gen Virol (1998) 1.54
Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Arch Virol (1989) 1.53
Localization of Drosophila retinal degeneration B, a membrane-associated phosphatidylinositol transfer protein. J Cell Biol (1993) 1.52
Interactions of murine gammaherpesvirus 68 with B and T cell lines. Virology (1993) 1.51
Identification of the genes encoding two capsid proteins of herpes simplex virus type 1 by direct amino acid sequencing. J Gen Virol (1990) 1.50
Genetic content and preliminary transcriptional analysis of a representative region of murine gammaherpesvirus 68. J Gen Virol (1997) 1.49
The DNA sequence of the RK strain of human herpesvirus 7. Virology (1998) 1.49
Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2015). Arch Virol (2015) 1.45
Cell-mediated immunity in herpes simplex virus-infected mice: functional analysis of lymph node cells during periods of acute and latent infection, with reference to cytotoxic and memory cells. J Gen Virol (1980) 1.45
Latent antigen vaccination in a model gammaherpesvirus infection. J Virol (2001) 1.45
DNA substrate structural requirements for the exonuclease and polymerase activities of procaryotic and phage DNA polymerases. Biochemistry (1989) 1.43
Membrane phenotype of murine effector and suppressor T cells involved in delayed hypersensitivity and protective immunity to herpes simplex virus. Cell Immunol (1983) 1.42
Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides. Nature (1986) 1.42
Loss of resolution in gel electrophoresis of RNA: a problem associated with the presence of formaldehyde gradients. Biotechniques (1993) 1.41
Role of antibody in primary and recurrent herpes simplex virus infection. J Virol (1985) 1.41
Imipramine treatment of alcoholism with comorbid depression. Am J Psychiatry (1993) 1.40
Characterization of the putative protein kinases specified by varicella-zoster virus genes 47 and 66. J Gen Virol (1994) 1.40
Interaction of Escherichia coli DNA polymerase I with azidoDNA and fluorescent DNA probes: identification of protein-DNA contacts. Biochemistry (1990) 1.38
Molecular cloning of the varicella-zoster virus genome and derivation of six restriction endonuclease maps. J Gen Virol (1983) 1.37
Modulation of MutS ATP hydrolysis by DNA cofactors. Biochemistry (2000) 1.37
Equine herpesviruses 2 and 5 are gamma-herpesviruses. Virology (1993) 1.36
The ribonucleotide reductase induced by herpes simplex virus type 1 involves minimally a complex of two polypeptides (136K and 38K). J Gen Virol (1985) 1.36
Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity. Immunology (1981) 1.36
Cryptosporidium in snakes with hypertrophic gastritis. Vet Pathol (1977) 1.35
Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gp110). J Virol (1994) 1.35
Analysis of the genome of equine herpesvirus type 1: arrangement of cleavage sites for restriction endonucleases EcoRI, BglII and BamHI. J Gen Virol (1981) 1.35
Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination. Vaccine (1999) 1.34
Distinct MutS DNA-binding modes that are differentially modulated by ATP binding and hydrolysis. J Biol Chem (2001) 1.31
Identification of the products of a varicella-zoster virus glycoprotein gene. J Gen Virol (1985) 1.31
Structural features of ribonucleotide reductase. Proteins (1986) 1.30
DNA sequence of the major inverted repeat in the varicella-zoster virus genome. J Gen Virol (1985) 1.28
DNA sequence of the US component of the varicella-zoster virus genome. EMBO J (1983) 1.26
Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res (2000) 1.25
Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection. Virology (1999) 1.25
The human herpesvirus-8 ORF 57 gene and its properties. J Gen Virol (1999) 1.25
Early promoter-binding factor from vaccinia virions. Proc Natl Acad Sci U S A (1987) 1.24